Revenue: The sum of all revenue fields included for a company's operating activities.
Assembly Biosciences, Inc. (ASMB) had Revenue of $9.42M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
Revenue |
$9.42M |
$-8.82M |
|
-- |
|
$9.42M |
|
$19.36M |
|
$-9.94M |
|
$1.12M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-9.94M |
|
$-10.42M |
|
7.51M |
|
7.51M |
|
$-1.17 |
|
$-1.17 |
|
Balance Sheet Financials | |
$95.53M |
|
$0.25M |
|
$3.49M |
|
$99.02M |
|
$46.63M |
|
-- |
|
$25.25M |
|
$71.88M |
|
$27.13M |
|
$27.13M |
|
$27.13M |
|
7.62M |
|
Cash Flow Statement Financials | |
$-23.44M |
|
$6.59M |
|
$1.92M |
|
$38.34M |
|
$23.41M |
|
$-14.93M |
|
$0.71M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-105.54% |
|
-105.54% |
|
-- |
|
-93.62% |
|
-93.62% |
|
$-23.44M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-32.50% |
|
-32.50% |
|
-8.91% |
|
-32.50% |
|
$3.56 |
|
$-3.12 |
|
$-3.12 |